Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China
· Delayed Price · Currency is CNY 17.14
+0.11 (0.65%)
At close: Mar 6, 2026
SHA:601607 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 57,095 | 69,396 | 56,107 | 60,072 | 49,277 | 47,493 | Upgrade
|
| Market Cap Growth | -14.99% | 23.68% | -6.60% | 21.91% | 3.75% | -0.60% | Upgrade
|
| Enterprise Value | 85,295 | 95,555 | 80,065 | 81,075 | 76,701 | 71,525 | Upgrade
|
| Last Close Price | 17.14 | 20.54 | 15.96 | 16.52 | 17.97 | 16.95 | Upgrade
|
| PE Ratio | 11.21 | 15.24 | 14.89 | 10.69 | 9.68 | 10.56 | Upgrade
|
| Forward PE | 21.49 | 22.41 | 8.08 | 14.04 | 10.35 | 11.36 | Upgrade
|
| PS Ratio | 0.20 | 0.25 | 0.22 | 0.26 | 0.23 | 0.25 | Upgrade
|
| PB Ratio | 0.64 | 0.83 | 0.70 | 0.77 | 0.83 | 0.87 | Upgrade
|
| P/TBV Ratio | 1.06 | 1.26 | 1.10 | 1.21 | 1.54 | 1.65 | Upgrade
|
| P/FCF Ratio | 17.75 | 20.25 | 24.82 | 29.18 | 52.28 | 12.39 | Upgrade
|
| P/OCF Ratio | 10.58 | 11.91 | 10.73 | 12.67 | 9.74 | 6.94 | Upgrade
|
| PEG Ratio | - | 1.51 | 0.67 | 1.17 | 0.84 | 0.84 | Upgrade
|
| EV/Sales Ratio | 0.30 | 0.35 | 0.31 | 0.35 | 0.36 | 0.37 | Upgrade
|
| EV/EBITDA Ratio | 8.38 | 9.30 | 7.94 | 8.37 | 8.55 | 8.15 | Upgrade
|
| EV/EBIT Ratio | 10.77 | 10.92 | 9.33 | 9.93 | 10.27 | 9.82 | Upgrade
|
| EV/FCF Ratio | 26.52 | 27.89 | 35.41 | 39.39 | 81.38 | 18.65 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 0.65 | 0.65 | 0.57 | 0.69 | 0.67 | Upgrade
|
| Debt / EBITDA Ratio | 5.79 | 4.97 | 4.82 | 4.29 | 4.24 | 3.90 | Upgrade
|
| Debt / FCF Ratio | 18.32 | 15.95 | 22.96 | 21.67 | 43.25 | 9.58 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.12 | 0.14 | 0.10 | 0.31 | 0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.52 | 1.00 | 1.12 | 0.78 | 2.05 | 1.64 | Upgrade
|
| Net Debt / FCF Ratio | 4.47 | 3.00 | 4.97 | 3.69 | 19.49 | 3.75 | Upgrade
|
| Asset Turnover | 1.22 | 1.27 | 1.27 | 1.28 | 1.38 | 1.34 | Upgrade
|
| Inventory Turnover | 6.33 | 6.48 | 6.45 | 6.55 | 7.32 | 6.77 | Upgrade
|
| Quick Ratio | 1.00 | 1.02 | 0.98 | 0.99 | 0.93 | 0.90 | Upgrade
|
| Current Ratio | 1.32 | 1.36 | 1.33 | 1.35 | 1.27 | 1.22 | Upgrade
|
| Return on Equity (ROE) | 7.91% | 7.16% | 6.53% | 10.20% | 11.03% | 10.77% | Upgrade
|
| Return on Assets (ROA) | 2.15% | 2.52% | 2.61% | 2.82% | 2.99% | 3.18% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.42% | 6.90% | 7.09% | 7.95% | 7.85% | 8.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.10% | 9.20% | 9.60% | 9.30% | 10.40% | 11.90% | Upgrade
|
| Earnings Yield | 9.89% | 6.56% | 6.72% | 9.35% | 10.34% | 9.47% | Upgrade
|
| FCF Yield | 5.63% | 4.94% | 4.03% | 3.43% | 1.91% | 8.07% | Upgrade
|
| Dividend Yield | 2.39% | 1.80% | 2.57% | 3.69% | 2.34% | 2.83% | Upgrade
|
| Payout Ratio | 50.60% | 79.16% | 105.66% | 55.08% | 52.54% | 53.79% | Upgrade
|
| Buyback Yield / Dilution | 0.93% | -0.07% | -6.28% | -22.54% | - | - | Upgrade
|
| Total Shareholder Return | 3.33% | 1.73% | -3.71% | -18.85% | 2.34% | 2.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.